In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...
There is a link on our Facebook page that you can share and you can also find the link it in our instagram bio until the ...
GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...
UK pharma group posts ‘statistically significant’ trial results for treatment combined with Blenrep pulled in 2022 ...
GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...